Ventyx Biosciences

We are a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2. Fraudulent Recruitment Alert *Please be aware of fraudulent job opportunities and offers not affiliated with Ventyx Biosciences* Unsuspecting individuals have reported receiving unsolicited contact and job offers from individual(s) purporting to be Ventyx employees. These perpetrators exploit individuals by getting them to reveal personal information by offering fraudulent employment opportunities and getting victims to provide sensitive personal and financial information. The fraud may include correspondence with fictitious Ventyx information publicly available including employee names, company logo, phone numbers, email addresses, and domains. Ventyx email will never come from addresses ending with @ventyxbiocareers.com or from an address that misspells our company name by swapping the x and y (we are Ventyx, not Ventxy). If you are unsure if a job opportunity is real or not visit the Ventyx careers page at https://ventyxbio.bamboohr.com/jobs/ FBI Warning on Cyber Criminals: https://www.ic3.gov/Media/Y2020/PSA200121 If you believe you have been the victim of a crime related to one of these scams, please contact your local law enforcement, the FBI’s Internet Crime Complaint Center, or the Federal Trade Commission (FTC).

网站

https://ventxybio.com/

Ventyx Biosciences的外部链接

所属行业

生物技术研究

规模

51-200 人

总部

Encinitas

类型

上市公司